NSE: ZYDUSLIFE · Healthcare
Zydus Lifesciences share price
NSE close 29 Oct 2026
Zydus Lifesciences share price chart, one year
Key figures
- 1M return
- −1.34%
- from 29 Sep 2026 close
- 3M return
- +5.50%
- from 29 Jul 2026 close
- 6M return
- +30.03%
- from 29 Apr 2026 close
- This year
- +29.53%
- from 31 Dec 2025 close
- 1Y return
- +18.10%
- from 29 Oct 2025 close
- 52-week closing high
- Rs 1,215.00
- 28 Sep 2026; latest close −2.52% from it
- 52-week closing low
- Rs 860.60
- 23 Mar 2026; latest close +37.62% from it
- Average turnover
- Rs 161.61 cr
- a session, 20 sessions to 28 Oct 2026
- Average delivery
- 51.3%
- of shares traded, weighted by volume
- Volume against its norm
- 0.6x
- 8,55,850 shares on 29 Oct 2026, against 14,10,751 a session
- Largest move, 3 months
- +6.43%
- on 11 Aug 2026
Against the Nifty 50, to 29 Oct 2026
| Period | ZYDUSLIFE | Nifty 50 | Difference, points |
|---|---|---|---|
| 1M | −1.34% | +0.97% | −2.31 |
| 3M | +5.50% | −5.42% | +10.91 |
| This year | +29.53% | −12.22% | +41.75 |
Zydus Lifesciences share price: questions
What is the share price of Zydus Lifesciences?
Zydus Lifesciences closed at Rs 1,184.40 on NSE on 29 October 2026, +0.76% on the day. Its NSE symbol is ZYDUSLIFE.
What is the 52-week high of Zydus Lifesciences?
The 52-week closing high of Zydus Lifesciences is Rs 1,215.00, set on 28 September 2026. The latest close is −2.52% from it. This is the highest close restated for splits and bonuses, not the intraday high.
What is the 52-week low of Zydus Lifesciences?
The 52-week closing low of Zydus Lifesciences is Rs 860.60, set on 23 March 2026. The latest close is +37.62% from it. This is the lowest close restated for splits and bonuses, not the intraday low.
How has Zydus Lifesciences performed against the Nifty 50 this year?
From the last close of 2025 to 29 October 2026, Zydus Lifesciences returned +29.53% and the Nifty 50 −12.22%: 41.75 percentage points ahead of the index. These are price returns, without dividends.
What is the return of Zydus Lifesciences over the last year?
To the NSE close on 29 October 2026, Zydus Lifesciences returned −1.34% over one month, +30.03% over six months, +18.10% over one year. These are price returns adjusted for splits and bonuses, without dividends.
How much of Zydus Lifesciences is traded on NSE on a typical day?
Over the 20 sessions to 28 October 2026, Zydus Lifesciences averaged Rs 161.61 crore of turnover and 14,10,751 shares a session, with 51.3% of shares delivered.
Have promoters or directors of Zydus Lifesciences traded its shares recently?
BSE filings since 1 August 2026 show no open-market trades in Zydus Lifesciences by its promoters, promoter group, directors or key managerial personnel.
Where these figures come from
Facts from NSE’s files and Oquilia’s own data, not investment advice.
- Prices are NSE closing prices from the daily bhavcopy. Returns chain each session's close against the previous close, adjusted for splits, bonuses, rights and demergers from NSE's corporate-action file, as on Oquilia's Market Movers pages; they exclude dividends.
- Turnover, volume and delivery average the 20 sessions before 29 Oct 2026 (29 Sep 2026 to 28 Oct 2026); delivery is weighted by volume.
- Insider figures: open-market trades by promoters, the promoter group, directors and key managerial personnel reported to BSE from 1 Aug 2026, matched to ZYDUSLIFE by company name (Zydus Lifesciences Ltd). ESOPs, gifts and off-market transfers are not counted; values are as filed, and values that cannot fit the share count are left out of totals. People appear by role as filed, not by name.
- Bulk and block deals: NSE publishes only the latest session's files, and Oquilia has stored them since 27 Oct 2026, so the 30-day window is complete only from then.
- NSE full bhavcopy, 2026-10-29 (close, volume, turnover, delivery)
- NSE index closes, 2026-10-29 (Nifty 50)
- BSE insider trading disclosures (SEBI PIT Regulation 7(2))
- Oquilia Insider and Pledge Radar
Figures as of the NSE close on 29 October 2026. See also all Nifty 500 share prices and market movers.